Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Constipation often occurs in the first month of Rybelsus therapy and is usually mild, improving with hydration, dietary fiber, exercise, and gentle laxatives. However persistent symptoms like no bowel movement for more than seven days, severe pain, blood in stool, or unexplained weight loss may indicate a serious problem.
See below for a full red flag checklist, detailed self care tips, and guidance on when to contact a healthcare professional.
Constipation is a known side effect of Rybelsus (oral semaglutide), a GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes. Experiencing "Rybelsus constipation after starting" therapy can be uncomfortable, but it isn't always cause for alarm. This guide helps you recognize when constipation is expected and when it may signal a more serious issue.
Rybelsus slows gastric (stomach) emptying and intestinal transit. This means:
Clinical trials and the FDA prescribing information for Rybelsus report constipation in up to 4–10% of users. Most cases are mild to moderate and resolve with simple lifestyle changes.
Understanding when constipation is common versus concerning helps you stay on track with your Rybelsus therapy:
Keyword focus: if you notice "Rybelsus constipation after starting" beyond the initial adjustment phase, keep an eye on severity and accompanying symptoms.
Use this checklist to decide if your constipation is within an expected side-effect range or if you should seek medical advice:
If you check any red-flag symptoms, speak immediately with a healthcare professional.
Most cases improve with basic self-care. Try these strategies:
Keep a simple diary noting food, water intake, bowel movement frequency, and any discomfort. This helps your care team adjust treatment if needed.
Even mild constipation can escalate. Contact your doctor if you experience:
In these situations, delays can lead to complications such as fecal impaction, bowel obstruction, or dehydration.
Unsure if your symptoms require immediate medical attention? Try Ubie's free AI-powered Constipation Symptom Checker for personalized insights based on your specific symptoms and medical history.
Rarely, severe constipation may force a treatment change. Your doctor may:
Never stop or change your diabetes treatment without medical supervision.
Maintaining open communication with your healthcare team ensures you can continue benefiting from Rybelsus while minimizing discomfort. Always consult your doctor or pharmacist before making any changes to your medication or self-care routine. If you notice serious or worsening symptoms, seek medical attention immediately—your health and safety come first.
(References)
* Aroda VR, Rosenstock J, Terauchi Y, et al. PIONEER 2: Efficacy and safety of once-daily oral semaglutide versus empagliflozin in patients with type 2 diabetes inadequately controlled with metformin: A randomized, open-label, phase 3a trial. Diabetes Care. 2019 Oct;42(10):1994-2003. PMID: 31444102.
* Knop FK, Rosenstock J, PIONEER Investigators. Efficacy and Safety of Oral Semaglutide in Patients With Type 2 Diabetes: A Pooled Analysis of the PIONEER Clinical Trial Programme. Diabetes Obes Metab. 2020 Jan;22(1):111-118. PMID: 31544487.
* Husain M, Bain SC, Holst AG, et al. Oral Semaglutide and Cardiovascular Outcomes in Patients With Type 2 Diabetes. N Engl J Med. 2019 Sep 19;381(12):1122-1133. PMID: 31494980.
* Chavez B, Patel R. Oral Semaglutide: A Novel Option for Type 2 Diabetes. Am J Health Syst Pharm. 2020 Feb 1;77(3):192-200. PMID: 31853683.
* Wilding JPH, Batterham RL, Buse JB, et al. Efficacy and Safety of Oral Semaglutide in Patients With Type 2 Diabetes Across the Spectrum of Baseline BMI: A Post Hoc Analysis of the PIONEER Clinical Trial Program. Diabetes Care. 2022 Mar 1;45(3):666-675. PMID: 35058229.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.